Plant-based quinoa burgers reduce post-meal blood sugar spikes
A study reveals that plant-based burgers with baru pulp and red quinoa trigger lower blood sugar spikes than glucose, highlighting their potential in nutrition.
A study reveals that plant-based burgers with baru pulp and red quinoa trigger lower blood sugar spikes than glucose, highlighting their potential in nutrition.
Asthma is the most common chronic disease and one of the main causes of hospitalization among children. The Global Asthma Network has estimated that its global prevalence is 9.1% for…
Changes to the heart linked to marathon running vary by age, sex, and training level, finds a synthesis of the available data, published in the open access journal BMJ Open…
In a target trial emulation using OneFlorida+ electronic health record data, GLP-1 receptor agonist use in adults with obesity and autoimmune disease was linked to lower hazards of pulmonary embolism,…
A systematic review of 105 studies found that climate change, water scarcity, land-use change, biofuel demand, trade disruptions, pandemics and conflict are major threats to maize, rice and wheat supplies.…
According to the National Aphasia Association, about 2 million U.S. citizens live with aphasia, but only two-thirds of Americans are aware of the condition, which is a communication disorder that…
Moderate screen time in the first 3 days after concussion is linked to faster recovery, with an average 141 minutes of daily use speeding up symptom resolution by 35%, finds…
Researchers at UTHealth Houston have identified different types of hidden systemic inflammation in patients with primary ciliary dyskinesia, even when they are not experiencing acute illness.
Difficulty conceiving a pregnancy may be associated with small differences in children's learning and behavior, according to a new study funded by the Environmental influences on Child Health Outcomes (ECHO)…
Once-weekly 9 mg mazdutide produced clinically meaningful weight loss in Chinese adults with obesity, reducing body weight by 16.65% after 60 weeks versus 1.50% with placebo. The phase 3 GLORY-2…